MoneyWorks4Me

Themis Medicare informs about outcome of board meeting

12 Feb 2021 Evaluate

Themis Medicare has informed that the Board of Directors at its meeting held today,12th February 2021, which commenced at 11.15 am and concluded at 2.30 pm, considered and approved the unaudited Standalone and Consolidated Financial Results for the Quarter and Nine months ended 31st December 2020. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter and nine months ended 31st December, 2020 is enclosed; and appointed SAV & Associates LLP as Secretarial Auditor for the financial year 2020-21 for the purpose of conducting Secretarial Audit.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..